Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback